Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10940153
Pharmaceutical compositions comprising meloxicam
granted -
US 10940160
Biomarkers for predicting responsiveness to decitabine therapy
granted -
US 10940142
Inhibition of crystal growth of roflumilast
granted -
US 10940133
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted -
US 10940109
Multilayer polymeric matrix based medical devices
granted -
US 10940141
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10941183
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
granted -
US 10940188
Compounds and methods for treatment and prevention of Flavivirus infection
granted -
US 10940211
Human antibodies to S. aureus hemolysin A toxin
granted -
US 10941140
IRAK inhibitors and method for making and using
granted -
US 10941213
Anti-TMPRSS2 antibodies and antigen-binding fragments
granted -
US 10941402
Chemically modified single-stranded RNA-editing oligonucleotides
granted -
US 10941187
GLP-1, exendin-4, peptide analogs and uses thereof
granted -
US 10941175
Pyrrolopyrimidine nucleosides and analogs thereof
granted -
CA 3152006
TROPOELASTINE DESTINEE A ETRE UTILISEE DANS LE TRAITEMENT DE LA CICATRISATION DE L'ACNE
granted -
US 10933022
Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
granted -
US 10934363
Chimeric antigen receptors based on single domain antibodies and methods of use thereof
granted -
US 10934550
Immunotherapy of cancer
granted -
US 10934349
Methods for increasing lean body mass with resistance training and a GDF8 inhibitor that is an anti-GDF8 antibody
granted -
US 10934306
Hepatitis B antiviral agents
granted -
US 10933081
Myostatin iRNA compositions and methods of use thereof
granted -
US 10934302
SHP2 phosphatase inhibitors and methods of use thereof
granted -
US 10933130
Vaccines with interleukin-33 as an adjuvant
granted -
US 10933094
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.